NRXN2

NRXN2 is a presynaptic cell-adhesion molecule that organizes excitatory synapses by binding the postsynaptic ligands LRRTM2 and NLGN2, and truncating mutations abolish both ligand binding and synaptogenic activity in coculture assays (PMID:21424692). The α-isoform (Nrxn2α) is the functionally dominant form at neocortical excitatory synapses, where its deletion reduces spontaneous glutamate release and impairs NMDAR-mediated transmission, likely through a trans-synaptic complex involving neuroligin and PSD-95 (PMID:25745399). NRXN2 expression is regulated post-transcriptionally by miR-873-5p, which directly represses NRXN2 mRNA (PMID:33262327), and by IGF2BP3-mediated stabilization of NRXN2 mRNA through m6A modification (PMID:41263466). Upstream, SMN deficiency alters Nrxn2 splicing and expression in motor neurons, placing NRXN2 downstream of SMN in neuromuscular synapse regulation (PMID:24218366).

1. 2011 High

   Establishing NRXN2 as a synapse organizer: truncating mutations were shown to abolish both LRRTM2/NLGN2 binding and synaptogenic activity, demonstrating that NRXN2 functions through trans-synaptic ligand interactions to promote synaptic differentiation.

   Evidence Neuron coculture differentiation assay and cell binding assay with recombinant LRRTM2/NLGN2 using truncating NRXN2 variants

   PMID:21424692

   Open questions at the time

   • Which specific extracellular domains are necessary and sufficient for each ligand interaction
   • Whether NRXN2 splice variants differentially engage LRRTM2 vs. NLGN2
   • Structural basis of the NRXN2–ligand interface not resolved
2. 2013 Medium

   Linking NRXN2 to motor neuron disease pathways: SMN deficiency was shown to alter Nrxn2 splicing and expression, and isoform-specific knockdown phenocopied SMA motor axon defects, placing NRXN2 as a functional effector downstream of SMN.

   Evidence Transcriptome analysis, live Ca²⁺ imaging, and isoform-specific morpholino knockdown in zebrafish SMA model; validated in Smn−/−;SMN2+/+ mouse motor neurons by RT-PCR

   PMID:24218366

   Open questions at the time

   • Mechanism by which SMN regulates Nrxn2 splicing (direct vs. indirect) not determined
   • Whether restoring Nrxn2 expression rescues SMA phenotypes in mammalian models
   • Single-lab finding in zebrafish with limited mammalian functional validation
3. 2015 High

   Defining the α-isoform as the critical form for excitatory transmission: Nrxn2α knockout reduced spontaneous excitatory release and NMDAR function in neocortex, while additional β-isoform deletion did not worsen the phenotype, establishing Nrxn2α as the functionally dominant isoform at excitatory synapses.

   Evidence Patch-clamp electrophysiology in Nrxn2α KO and Nrxn2α/β double-KO mouse neocortical slices; synapse density and ultrastructure analysis

   PMID:25745399

   Open questions at the time

   • Whether the NMDAR deficit is due to altered surface expression, trafficking, or signaling through neuroligin–PSD-95
   • Whether inhibitory synaptic functions of Nrxn2 become apparent in other brain regions
   • Molecular identity of the trans-synaptic complex mediating NMDAR regulation not directly shown
4. 2019 Medium

   Extending the functional impact to circuit-level wiring: Nrxn2α deletion was shown to alter structural connectivity in socially relevant brain regions, linking synaptic-level adhesion loss to macroscale white-matter changes relevant to social behavior circuits.

   Evidence Diffusion tensor MRI at 9.4 T combined with CLARITY immunolabeling in Nrxn2α KO mouse brains

   PMID:30858964

   Open questions at the time

   • Whether structural changes are developmental or reflect ongoing synaptic dysfunction
   • Causal relationship between connectivity changes and behavioral phenotypes not established
   • Single-lab imaging study without electrophysiological correlation in the same regions
5. 2020 Medium

   Identifying a post-transcriptional regulator: miR-873-5p was shown to directly repress NRXN2 mRNA, and an ASD-associated seed-region variant altered this regulation, revealing a layer of miRNA-mediated control over NRXN2 expression.

   Evidence Dual-luciferase reporter assay and qPCR in transfected SH-SY5Y neuroblastoma cells

   PMID:33262327

   Open questions at the time

   • Effect size of miR-873 on endogenous NRXN2 protein levels in neurons not measured
   • Whether the ASD-associated miR-873 variant affects NRXN2-dependent synaptic function in vivo
   • Other miRNA regulators of NRXN2 not systematically surveyed
6. 2025 Medium

   Revealing epitranscriptomic regulation: IGF2BP3 was shown to stabilize NRXN2 mRNA through recognition of a specific m6A site, and mutation of this site destabilized the transcript and suppressed AML cell proliferation, uncovering an m6A-dependent regulatory axis for NRXN2 outside the nervous system.

   Evidence MeRIP-qPCR, RNA immunoprecipitation, m6A site-directed mutagenesis (c.1770A>T), siRNA knockdown and overexpression in HL-60 AML cells

   PMID:41263466

   Open questions at the time

   • Relevance of IGF2BP3–m6A regulation of NRXN2 in neuronal contexts not tested
   • Whether NRXN2 protein is functionally important in AML or is a bystander transcript
   • Single-lab study in one AML cell line without in vivo validation

• The structural basis of NRXN2's selective engagement with different postsynaptic ligands, the molecular mechanism by which Nrxn2α controls NMDAR function trans-synaptically, and whether NRXN2 plays functional roles outside the nervous system remain unresolved.
• No crystal structure of NRXN2 in complex with LRRTM2 or NLGN2
• Trans-synaptic signaling cascade from Nrxn2α to NMDAR subunit composition or trafficking undefined
• Functional significance of NRXN2 expression in non-neuronal tissues (e.g., AML) unclear